Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Impact of body mass index on posttransplant outcomes reexamined.

Literature DB >> 26264149

Impact of body mass index on posttransplant outcomes reexamined.

Khurram Bari¹, Pratima Sharma².

Abstract

Entities: Chemical Disease Species

Mesh：

Year: 2015 PMID： 26264149 PMCID： PMC4691840 DOI： 10.1002/lt.24227

Source DB: PubMed Journal: Liver Transpl ISSN： 1527-6465 Impact factor: 5.799

× No keyword cloud information.

13 in total

1. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.

Authors: D E Schaubel; C S Sima; N P Goodrich; S Feng; R M Merion
Journal: Am J Transplant Date: 2008-01-07 Impact factor: 8.086

2. Sarcopenia and mortality after liver transplantation.

Authors: Michael J Englesbe; Shaun P Patel; Kevin He; Raymond J Lynch; Douglas E Schaubel; Calista Harbaugh; Sven A Holcombe; Stewart C Wang; Dorry L Segev; Christopher J Sonnenday
Journal: J Am Coll Surg Date: 2010-06-26 Impact factor: 6.113

3. Prevalence of obesity in the United States.

Authors: Cynthia L Ogden; Margaret D Carroll; Katherine M Flegal
Journal: JAMA Date: 2014-07 Impact factor: 56.272

4. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.

Authors: Paul Martin; Andrea DiMartini; Sandy Feng; Robert Brown; Michael Fallon
Journal: Hepatology Date: 2014-03 Impact factor: 17.425

5. Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation.

Authors: Robert W Krell; Daniel R Kaul; Andrew R Martin; Michael J Englesbe; Christopher J Sonnenday; Shijie Cai; Preeti N Malani
Journal: Liver Transpl Date: 2013-10-21 Impact factor: 5.799

6. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.

Authors: Kiran M Bambha; Jennifer L Dodge; Jane Gralla; David Sprague; Scott W Biggins
Journal: Liver Transpl Date: 2015-10 Impact factor: 5.799

2. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.

Authors: Martha M Kirstein; Thorsten Book; Michael P Manns; Thomas von Hahn; Torsten Voigtländer
Journal: United European Gastroenterol J Date: 2020-05-04 Impact factor: 4.623

2 in total

Impact of body mass index on posttransplant outcomes reexamined.

1. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.

2. Sarcopenia and mortality after liver transplantation.

3. Prevalence of obesity in the United States.

4. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.

5. Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation.

6. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.

7. Liver transplantation at the extremes of the body mass index.

8. Prolonged waiting times for liver transplantation in obese patients.

9. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

10. Effect of body mass index on the survival benefit of liver transplantation.

1. Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients.

2. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.